Search

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17–22, in San Diego, California.

… Tuesday, April 14, 2026 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery at the American Association for Cancer Research (AACR) Annual Meeting 2026

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two cancer hospital in the nation, and the number one hospital for urology care by U.S. News & World Report in its annual Best Hospitals list. MSK has held its position as a top-two cancer hospital in the U.S. and the best cancer center in the Northeast since these rankings were established 35 years ago.

… Tuesday, July 16, 2024 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two cancer hospital in the nation, and the number one hospital for urology care by U.S. News & World Report in its annual Best Hospitals list. MSK has held its

MSK researchers have led much of the research looking at how people with blood cancers respond to COVID-19 infections and vaccines.

… Tuesday, December 21, 2021 Doctors and scientists at Memorial Sloan Kettering Cancer Center have played a leading role in understanding how COVID-19 affects people with cancer. MSK investigators have published a number of pioneering studies on the topic, which have contributed to the care of patients

… Wednesday, August 3, 2022 First, the good news: There’s no evidence that tattoos cause skin cancer , says Memorial Sloan Kettering Cancer Center (MSK) dermatologist Jennifer DeFazio , who cares for people at the MSK Skin Cancer Center Hauppauge . A dermatologist is a doctor who specializes in skin, hair

New MSK research combined sophisticated genetically engineered mouse models and advanced computational methods to map the earliest cell states leading to pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.

… Thursday, May 11, 2023 Discussions of cancer often stress the genetic mutations that drive disease by altering the normal function of cellular proteins. KRAS , for example, normally acts as an on/off switch for cellular proliferation, but mutations to the gene — common in lung cancer, colorectal cancer

Ingo Mellinghoff is optimistic about the future of brain cancer treatments as the new Chair of MSK’s Department of Neurology.

… Thursday, March 11, 2021 Summary Neuro-oncologist Ingo Mellinghoff first became intrigued by scientific questions regarding brain tumors while working in the lab of physician-scientist Charles Sawyers before both came to MSK. Now, Dr. Mellinghoff leads MSK’s Department of Neurology as it deploys innovative

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo Oviedo-Mori survive — and thrive — with advanced lung cancer for 15 years.

… Monday, March 10, 2025 It was a hot, humid night in 2010 when Giancarlo Oviedo-Mori and his parents sat in a Bronx hospital and received the shock of their lives. They learned that he had advanced  non-small cell lung cancer . He was only 18 years old and had big dreams. “Every South American kid wants

Obtenga información sobre cómo la nueva investigación y los ensayos clínicos en el Memorial Sloan Kettering Cancer Center (MSK) han ayudado a Giancarlo Oviedo-Mori, de 32 años, a sobrevivir, y prosperar, con cáncer pulmonar avanzado durante 15 años.

… Monday, March 10, 2025 Una noche calurosa y húmeda de 2010, Giancarlo Oviedo-Mori y sus padres recibieron la sorpresa más impactante de sus vidas mientras estaban sentados en un hospital del Bronx. Se enteraron de que Giancarlo padecía un  cáncer pulmonar avanzado de células no pequeñas . Tenía tan solo

What proportion of cancer patients are eligible to benefit from precision oncology? There is an ongoing debate on this issue, partly due to a lack of consensus on which gene mutations are clinically actionable.

… Wednesday, October 18, 2023 What proportion of cancer patients are eligible to benefit from precision oncology? There is an ongoing debate on this issue, partly due to a lack of consensus on which gene mutations are clinically actionable. To answer the question, researchers at Memorial Sloan Kettering

Experts at Memorial Sloan Kettering Cancer Center reviewed the research and found that whole food plant based diets are better than ketogenic diets at reducing cancer risk and helping people after cancer treatment live healthier lives.

… Monday, July 25, 2022 People have sought answers about the relationship between nutrition and health throughout history. In the past few decades, scientific research has uncovered important insights about our diets and cancer, including how food can affect our risk of developing the disease, the treatment